Ignite Creation Date:
2025-12-24 @ 1:12 PM
Ignite Modification Date:
2025-12-28 @ 12:26 AM
Study NCT ID:
NCT04339595
Status:
TERMINATED
Last Update Posted:
2021-12-08
First Post:
2020-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Long-Term Treatment Effect With Tildrakizumab in Participants With Plaque Psoriasis
Sponsor:
Almirall, S.A.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
M-14745-44
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None